Zhenshun Song

Prof. Dr. Zhenshun Song


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in The American Journal of Surgery
Verified
Journal Article
Closed access
JHJie Hua
Jie Hua
JGJian Gong
Jian Gong
LYLe Yao
Le Yao
BZBo Zhou
Bo Zhou
ZSZhenshun Song
Zhenshun Song

5 December 2016 in Scientific Reports
Verified
Journal Article
Open access
ZHZhigang He
Zhigang He
JHJie Hua
Jie Hua
DQDaohai Qian
Daohai Qian
JGJian Gong
Jian Gong
SLShengping Lin
Shengping Lin
ZSZhenshun Song
Zhenshun Song
The administration of mesenchymal stem cells/multipotent mesenchymal stromal cells (MSCs) to enhance tissue repair is currently undergoing clinical trials. Some studies, including our previous work, have also revealed the beneficial effect of MSCs in severe acute pancreatitis (SAP); however, their mechanisms or mode of action remain controversial. In this study, we demonstrated that intravenously (i.v.)-administered human MSCs (hMSCs) remarkably promoted recovery from experimental SAP without significant engraftment of hMSCs in the damaged pancreas. Interestingly, we found that i.v.-administered hMSCs with knockdown of TSG-6 expression lost most of their anti-inflammatory effects and thus could not significantly ameliorate SAP. As expected, the effects of hMSCs were also duplicated by i.v. infusion of recombinant TSG-6. Furthermore, our results showed that the increase of oxidative stress, activation of the NLRP3 inflammasome and NF-κB signaling in SAP was substantially inhibited following administration of hMSCs or TSG-6, which was dependent on the presence of CD-44 receptors in acinar cells. In conclusion, our study, for the first time, revealed that novel mechanisms are responsible for the immunomodulatory effect of i.v. hMSCs.

7 October 2013 in Cell Biology International
Verified
Journal Article
Closed access
PDF file
JHJie Hua
Jie Hua
JGJian Gong
Jian Gong
HMHongbo Meng
Hongbo Meng
BXBin Xu
Bin Xu
LYLe Yao
Le Yao
ZSZhenshun Song
Zhenshun Song

6 July 2023 in Advanced Science
Verified
Journal Article
Open access
ZHZhengyu Hu
Zhengyu Hu
DWDongyan Wang
Dongyan Wang
JGJian Gong
Jian Gong
YLYan Li
Yan Li
ZMZhilong Ma
Zhilong Ma
ZSZhenshun Song
Zhenshun Song
Mitochondrial function impairment due to abnormal opening of the mitochondrial permeability transition pore (MPTP) is considered the central event in acute pancreatitis; however, therapeutic choices for this condition remain controversial. Mesenchymal stem cells (MSCs) are a family member of stem cells with immunomodulatory and anti‐inflammatory capabilities that can mitigate damage in experimental pancreatitis. Here, it is shown that MSCs deliver hypoxia‐treated functional mitochondria to damaged pancreatic acinar cells (PACs) via extracellular vesicles (EVs), which reverse the metabolic function of PACs, maintain ATP supply, and exhibit an excellent injury‐inhibiting effect. Mechanistically, hypoxia inhibits superoxide accumulation in the mitochondria of MSCs and upregulates the membrane potential, which is internalized into PACs via EVs, thus, remodeling the metabolic state. In addition, cargocytes constructed via stem cell denucleation as mitochondrial vectors are shown to exert similar therapeutic effects to MSCs. These findings reveal an important mechanism underlying the role of mitochondria in MSC therapy and offer the possibility of applying mitochondrial therapy to patients with severe acute pancreatitis.

1 October 2015 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
JHJie Hua
Jie Hua
ZHZhigang He
Zhigang He
DQDaohai Qian
Daohai Qian
HMHongbo Meng
Hongbo Meng
BZBo Zhou
Bo Zhou
ZSZhenshun Song
Zhenshun Song

1 August 2021 in Science of The Total Environment
Verified
Journal Article
Closed access
ZHZhengyu Hu
Zhengyu Hu
YLYan Li
Yan Li
YYYuexin Yang
Yuexin Yang
WYWeidi Yu
Weidi Yu
WXWangcheng Xie
Wangcheng Xie
ZSZhenshun Song
Zhenshun Song